A carregar...
Nanoparticles Presenting Potent TLR7/8 Agonists Enhance Anti-PD-L1 Immunotherapy in Cancer Treatment
[Image: see text] Cancer immunotherapy can be augmented with toll-like receptor agonist (TLRa) adjuvants, which interact with immune cells to elicit potent immune activation. Despite their potential, use of many TLRa compounds has been limited clinically due to their extreme potency and lack of phar...
Na minha lista:
| Publicado no: | Biomacromolecules |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American
Chemical Society
2020
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497526/ https://ncbi.nlm.nih.gov/pubmed/32816460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.biomac.0c00812 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|